Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

860 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study).
Bai F, Aldieri C, Cattelan A, Raumer F, Di Meco E, Moioli MC, Tordato F, Morelli P, Borghi F, Rizzi M, Van Hauwermeiren E, Castelli F, Migliorino G, Menzaghi B, Rizzardini G, Saracino A, Cascio A, Puoti M, d'Arminio Monforte A, Marchetti G. Bai F, et al. Among authors: rizzi m. Expert Rev Anti Infect Ther. 2020 Dec;18(12):1271-1279. doi: 10.1080/14787210.2020.1798227. Epub 2020 Aug 14. Expert Rev Anti Infect Ther. 2020. PMID: 32797758 Free article.
Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI).
Rizzi M, Ravasio V, Carobbio A, Mattucci I, Crapis M, Stellini R, Pasticci MB, Chinello P, Falcone M, Grossi P, Barbaro F, Pan A, Viale P, Durante-Mangoni E; Investigators of the Italian Study on Endocarditis. Rizzi M, et al. BMC Infect Dis. 2014 Apr 29;14:230. doi: 10.1186/1471-2334-14-230. BMC Infect Dis. 2014. PMID: 24779617 Free PMC article.
Infective endocarditis in patients with hepatic diseases.
Seminari E, De Silvestri A, Ravasio V, Ludovisi S, Utili R, Petrosillo N, Castelli F, Bassetti M, Barbaro F, Grossi P, Barzaghi N, Rizzi M, Minoli L. Seminari E, et al. Among authors: rizzi m. Eur J Clin Microbiol Infect Dis. 2016 Feb;35(2):279-84. doi: 10.1007/s10096-015-2541-4. Epub 2015 Dec 21. Eur J Clin Microbiol Infect Dis. 2016. PMID: 26690071
Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis.
Giuliano S, Guastalegname M, Russo A, Falcone M, Ravasio V, Rizzi M, Bassetti M, Viale P, Pasticci MB, Durante-Mangoni E, Venditti M. Giuliano S, et al. Among authors: rizzi m. Expert Rev Anti Infect Ther. 2017 Sep;15(9):807-818. doi: 10.1080/14787210.2017.1372749. Epub 2017 Sep 14. Expert Rev Anti Infect Ther. 2017. PMID: 28903607 Review.
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres.
Comelli A, Genovese C, Lombardi A, Bobbio C, Scudeller L, Restelli U, Muscatello A, Antinori S, Bonfanti P, Casari S, Castagna A, Castelli F, Monforte AD, Franzetti F, Grossi P, Lupi M, Morelli P, Piconi S, Puoti M, Pusterla L, Regazzetti A, Rizzi M, Rusconi S, Zuccaro V, Gori A, Bandera A; ASP Lomb Study Group. Comelli A, et al. Among authors: rizzi m. Antimicrob Resist Infect Control. 2022 Aug 29;11(1):108. doi: 10.1186/s13756-022-01152-5. Antimicrob Resist Infect Control. 2022. PMID: 36038903 Free PMC article.
Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort.
Durante-Mangoni E, Pafundi PC, Ravasio V, Barbaro F, Bassetti M, Chinello P, Falcone M, Pasticci MB, Scotton PG, Stellini R, Tripodi MF, Utili R, Rizzi M. Durante-Mangoni E, et al. Among authors: rizzi m. Infection. 2016 Aug;44(4):467-74. doi: 10.1007/s15010-015-0870-y. Epub 2016 Jan 19. Infection. 2016. PMID: 26780903
Rilpivirine plus cobicistat-boosted darunavir as a two-drug switch regimen in HIV-infected, virologically suppressed subjects on steady standard three-drug therapy: a randomized, controlled, non-inferiority trial (PROBE 2).
Maggiolo F, Gianotti N, Comi L, Di Filippo E, Fumagalli L, Nozza S, Galli L, Valenti D, Rizzi M, Castagna A. Maggiolo F, et al. Among authors: rizzi m. J Antimicrob Chemother. 2020 May 1;75(5):1332-1337. doi: 10.1093/jac/dkaa018. J Antimicrob Chemother. 2020. PMID: 32129855 Clinical Trial.
860 results